| abstract |
IκB-β polypeptides and polynucleotides and methods for producing such polypeptides bynrecombinant techniques are disclosed. Also disclosed are methods for utilizing IκB-βnpolypeptides and polynucleotides in the design of protocols for the treatment of inflammatorynconditions including but not limited to rheumatoid arthritis, dermatosis (eg. psoriasis),ninflammatory bowel disease, autoimmune diseases, tissue and/or organ rejection, Alzheimer'sndisease, stroke, atherosclerosis, restenosis, cancer, viral infection including but not limited tonAIDS, osteoarthritis, osteoperosis, and Ataxia Telangiestasia, among others, and diagnosticnassays for such conditions. |